SCHEMBL3357775

SCHEMBL3357775

CC(C)Cc1cc2sccc2c(Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
ESR1 P03372 2/20 0.36
PDE7A Q13946 1/20 0.34
HTR2C P28335 2/20 0.33
HTR2A P28223 1/20 0.33
CSNK2A2 P19784 5/20 0.32
CSNK2B P67870 5/20 0.32
CSNK2A1 P68400 5/20 0.32
IKBKB O14920 1/20 0.32
PDE3B Q13370 2/20 0.32
PDE3A Q14432 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
KDM4E B2RXH2 1/20 0.31
PTGER1 P34995 1/20 0.30
GPR139 Q6DWJ6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8172184 0.74 KDM4E (0.39) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL25346159 0.73 CSNK2A2 (0.37) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL31155205 0.73 CSNK2A2 (0.37) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL20745977 0.70 CSNK2A2 (0.35) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL6240033 0.70 CSNK2A2 (0.35) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL5198824 0.70 SMN1; SMN2 (0.36) HTR2CCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL7260119 0.68 MAOA (0.37) NOS3NOS1NOS2ESR1HTR2C
SCHEMBL24799425 0.67 NOS2 (0.48) NOS3NOS1NOS2ESR1IKBKB
SCHEMBL4769008 0.64 KDM4E (0.46) KDM4EMAPT
SCHEMBL4773700 0.64 MAPT (0.39) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797099-B1 PIPERIDINYLAMINO-THIENO[2,3-D] PYRIMIDINE COMPOUNDS EPIX DELAWARE INC (US) 2010-08-11 EP disclosed